As of 2025-05-18, the EV/EBITDA ratio of Net Medical Xpress Solutions Inc (NMXS) is 0.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NMXS's latest enterprise value is -0.04 mil USD. NMXS's TTM EBITDA according to its financial statements is -0.21 mil USD. Dividing these 2 quantities gives us the above NMXS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 9.4x | 6.9x |
| Forward P/E multiples | 5.1x - 15.6x | 7.4x |
| Fair Price | (0.02) - (0.05) | (0.04) |
| Upside | -895.6% - -1680.0% | -1275.0% |
| Date | EV/EBITDA |
| 2025-03-11 | -0.95 |
| 2025-03-07 | -1.00 |
| 2025-02-28 | -1.22 |
| 2025-02-25 | -1.22 |
| 2025-02-21 | -0.72 |
| 2025-02-19 | -0.79 |
| 2025-02-18 | -0.79 |
| 2025-02-12 | -0.85 |
| 2025-02-05 | -0.72 |
| 2025-01-29 | -1.02 |
| 2025-01-24 | -0.95 |
| 2025-01-08 | -0.72 |
| 2025-01-03 | -0.72 |
| 2024-12-26 | -0.72 |